Cover Image

P55 Client acceptability and feasibility of expanded access to direct acting antiviral therapy for hepatitis at the Kirketon Road Centre

Saved in:

Bibliographic Details
Main Authors:	K.J. Chronister (Author), R. Lothian (Author), J. Kearley (Author), R. Gilliver (Author), P. Read (Author)
Format:	Book
Published:	Elsevier, 2017-08-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

O10 Treatment of Aboriginal and Torres Strait Islander clients with direct acting antivirals at the Kirketon Road Centre
by: R. Gilliver, et al.
Published: (2017)

P54 Treatment adherence among people who inject drugs taking directly observed direct acting antiviral therapy at Kirketon Road Centre
by: K.J. Chronister, et al.
Published: (2017)

P02.55. Craniosacral therapy for migraine: a feasibility study
by: Mann J, et al.
Published: (2012)

Antiviral Effects of Oleandrin
by: Newman RA, et al.
Published: (2020)

Virus infection and direct-acting antivirals in pregnancy
by: Xuan Huang, et al.
Published: (2022)

Assessment of the feasibility of exon 45-55 multiexon skipping for duchenne muscular dystrophy
by: van Ommen Gert-Jan B, et al.
Published: (2008)

Bioequivalent pharmacokinetics for generic and originator hepatitis C direct-acting antivirals
by: Andrew Hill, et al.
Published: (2018)

IP-10 Interferes With the Antiviral Response of Direct-Acting Antiviral Agents for Hepatitis C Virus Infection
by: Yadong Wang, et al.
Published: (2022)

P20 Monitoring the uptake of hepatitis C: direct acting antiviral treatment in Australia
by: B. Hajarizadeh, et al.
Published: (2017)

Direct Acting Antiviral Drugs: Pharmacokinetics and Drug-Drug Interactions
by: Marina Barakat, et al.
Published: (2022)

Hepatitis C virus pharmacogenomics in Latin American populations: implications in the era of direct-acting antivirals
by: Trinks J, et al.
Published: (2017)

Superior Treg-Expanding Properties of a Novel Dual-Acting Cytokine Fusion Protein
by: Tanja Padutsch, et al.
Published: (2019)

Enhancing a Client-Centred Practice with the Canadian Occupational Performance Measure
by: A. Enemark Larsen, et al.
Published: (2018)

The care for the surgical client: a guide act to reach welfare. A bibliographic review
by: Élissa Jôse E. R. Cruz, et al.
Published: (2006)

Feasibility, acceptability, and sustainability of Project ECHO to expand capacity for pediatricians in Vietnam
by: Le Hong Nhung, et al.
Published: (2021)

Multilayer Nanocarrier for the Codelivery of Interferons: A Promising Strategy for Biocompatible and Long-Acting Antiviral Treatment
by: Thelvia I. Ramos, et al.
Published: (2024)

Price of a hepatitis C cure: Cost of production and current prices for direct-acting antivirals in 50 countries
by: Melissa J. Barber, et al.
Published: (2020)

Adoption of direct-acting antiviral medications for hepatitis C: a retrospective observational study
by: Leah L. Zullig, et al.
Published: (2019)

The effect of cognitive emotion regulation on direct-acting antivirals adherence in patients with hepatitis C
by: Adina Turcu-Stiolica, et al.
Published: (2024)

Strategies for treating and managing chronic hepatitis C in children in the direct-acting antiviral era
by: Suk-Jin Hong, et al.
Published: (2020)

The changing landscape of antiviral treatment of herpes zoster: a 17-year population-based cohort study
by: Friesen KJ, et al.
Published: (2016)

Expanding reimbursement of immediate treatment using direct acting antivirals to reduce hepatitis C incidence among HIV positive men who have sex with men in Bangkok, Thailand: A cost effectiveness modelling study
by: Shreoshee Mukherjee, et al.
Published: (2021)

Continuum of hepatitis C care cascade in prison and following release in the direct-acting antivirals era
by: Sanam Hariri, et al.
Published: (2020)

Direct-Acting Antivirals and Host-Targeting Approaches against Enterovirus B Infections: Recent Advances
by: Chiara Tammaro, et al.
Published: (2023)

Retrospective Evaluation on Patient Screening and Counseling Service on Direct-acting Antivirals Against Hepatitis C
by: Bob Ka Him Wong, et al.
Published: (2020)

Effect of direct-acting antivirals on elastographic measures in patients with chronic hepatitis C virus infection
by: Mohamed M Sakr, et al.
Published: (2019)

Direct-acting antivirals for chronic Hepatitis C are effective and safe: an observational study in Londrina/PR
by: Hodnei Takashi Machado, et al.
Published: (2022)

Direct Acting Antivirals in Hepatitis C-Infected Kidney Transplant Recipients: Associations with Long-term Graft Failure and Patient Mortality
by: Michael R Goetsch, et al.
Published: (2020)

Teenage girls' anorexia in the light of research - the road to success or the act of slow self-destruction
by: Hubert Sommer
Published: (2017)

O19 Towards hepatitis C eradication in far North Queensland: a report on models of care and direct acting antiviral outcomes
by: A. Lee, et al.
Published: (2017)

Bispidine-amino acid conjugates act as a novel scaffold for the design of antivirals that block Japanese encephalitis virus replication.
by: V Haridas, et al.
Published: (2013)

The effectiveness and safety of direct-acting antivirals for hepatitis C virus treatment: A single-center experience in Saudi Arabia
by: Sumaiah J. Alarfaj, et al.
Published: (2022)

Chemical Behavior and Bioactive Properties of Spinorphin Conjugated to 5,5'-Dimethyl- and 5,5'-Diphenylhydantoin Analogs
by: Stela Georgieva, et al.
Published: (2024)

Perceived physical health outcomes of direct-acting antiviral treatment for hepatitis C: a qualitative study
by: Stelliana Goutzamanis, et al.
Published: (2021)

Hepatitis C: sociodemographic and clinical profile of patients treated with direct-acting antivirals in a pharmaceutical office
by: Karem Aline Pegoraro, et al.
Published: (2023)

Timing Strategies of Direct-Acting Antivirals and Biologics Administration in HCV-Infected Subjects with Inflammatory Bowel Diseases
by: Nicola Imperatore, et al.
Published: (2017)

Emergence and Persistence of Resistance-Associated Substitutions in HCV GT3 Patients Failing Direct-Acting Antivirals
by: Saima Mushtaq, et al.
Published: (2022)

Predicting Treatment Failure for Initiators of Hepatitis C Virus Treatment in the era of Direct-Acting Antiviral Therapy
by: Nadia A. Nabulsi, et al.
Published: (2020)

Patients' preferences for treatment with the new direct acting antiviral therapies for chronic hepatitis C virus infection
by: MA Simón, et al.
Published: (2021)

Is direct-acting antiviral treatment beneficial or harmful for patients with hepatitis C virus-related hepatocellular carcinoma?
by: Hye Won Lee
Published: (2022)